PBS updates

Tysabri (Natalizumab)

natalizumab 150 mg/mL injection, 2 x 1 mL syringes · INJECTION · PBS code 13820J

STREAMLINED

What it costs

AU$604.89 PBS-determined price per 2 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2024-02-01.
  • • Repeats: 5.
  • • PBS program: HS.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Clinically definite relapsing-remitting multiple sclerosis


Must be treated by a neurologist; AND

The treatment must be the sole PBS-subsidised disease modifying therapy for this condition; AND

Patient must be ambulatory (without assistance or support); AND

Patient must have experienced at least 2 documented attacks of neurological dysfunction, believed to be due to multiple sclerosis, in the preceding 2 years of commencing a PBS-subsidised disease modifying therapy for this condition; AND

The condition must be confirmed by magnetic resonance imaging of the brain and/or spinal cord; or

Patient must be deemed unsuitable for magnetic resonance imaging due to the risk of physical (not psychological) injury to the patient.

The date of the magnetic resonance imaging scan must be included in the patient's medical notes, unless written certification is provided, in the patient's medical notes, by a radiologist that an MRI scan is contraindicated because of the risk of physical (not psychological) injury to the patient.

Treatment with this drug must cease if there is continuing progression of disability whilst the patient is being treated with this drug.

For continued treatment the patient must demonstrate compliance with, and an ability to tolerate, this drug.

Sponsor: Biogen Australia Pty Ltd ABN 30 095 760 115

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.